{
    "nct_id": "NCT02956798",
    "official_title": "Phase II Trial of SAbR for Patients With Oligometastatic Renal Cell Carcinoma",
    "inclusion_criteria": "* Metastatic renal cell carcinoma with limited measurable extracranial metastases (Limited metastases, or oligometastases, defined as ≤3 sites of metastasis).\n* Radiographic evidence of metastatic disease. CT should be performed within 30 days of registration.\n* Pathology confirmation of Renal cell carcinoma.\n* Prior surgery, or radiation is permitted.\n* Age ≥ 18 years.\n* Women of child-bearing potential and men must agree to use adequate contraception (hormonal or barrier method of birth control; abstinence) prior to study entry, and for 90 days after Radiation treatment has been completed . Should a woman become pregnant or suspect she is pregnant while participating in this study, she should inform her treating physician immediately.\n\nA female of child-bearing potential is any woman (regardless of sexual orientation, having undergone a tubal ligation, or remaining celibate by choice) who meets the following criteria:\n\n* Has not undergone a hysterectomy or bilateral oophorectomy; or\n* Has not been naturally postmenopausal for at least 12 consecutive months (i.e., has had menses at any time in the preceding 12 consecutive months).\n\n  * Ability to understand and the willingness to sign a written informed consent and agrees to undergo image studies and follow up\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Subjects with brain metastasis as assessed by contrast MRI or contrast CT scans(contrast recommended).\n* Subjects with previous history of brain metastasis.\n* Subjects that received prior systemic therapy for kidney cancer in the past 1 year, except one line of immuno- or cytokine therapy (e.g. prior IL-2); systemic therapy for other cancers does not apply to this exclusion criteria\n* Subjects with ≥3 unfavorable prognostic factors defined by Motzer et al. (1999), (KPS <80% or ECOG>1, Hgb < LLN, LDH >1.5x normal, corrected serum calcium >10mg/dl and absence of prior nephrectomy), Patients with 0, 1-2, and ≥3 factors had time to death of 20 months, 10 months and 4 months.\n* Subjects with life expectancy < 6 months.\n* Subjects receiving any other investigational agents\n* Subjects must not be pregnant due to the potential for congenital abnormalities and the potential of this regimen to harm nursing infants.",
    "miscellaneous_criteria": ""
}